⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

May 8, 2020Expert Opinion on Biological TherapyOpen Access

Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?

Leticia Moreno‐Fierros Ileana García-Silva Sergio Rosales‐Mendoza

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 virus is having an unprecedented impact on global health derived from its quick spread, which is attributed to its high stability under environment...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Moreno‐Fierros et al. (2020) studied this question.

synapsesocial.com/papers/6a9415e1c4f6ae35ff1d4b96 https://doi.org/10.1080/14712598.2020.1767062

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS CoronavirusOriginal Research · 2020 · 4,415 citations
2Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronavirusesOriginal Research · 2005 · 250 citations
3Cross-Neutralization of Human and Palm Civet Severe Acute Respiratory Syndrome Coronaviruses by Antibodies Targeting the Receptor-Binding Domain of Spike ProteinOriginal Research · 2006 · 118 citations
4Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responsesOriginal Research · 2016 · 160 citations
5Parenteral Vaccination With a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to M. Tuberculosis InfectionOriginal Research · 2019 · 25 citations
6Subunit Vaccines Against Emerging Pathogenic Human CoronavirusesReview · 2020 · 426 citations
7Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brainOriginal Research · 2012 · 52 citations
8Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responsesOriginal Research · 2010 · 63 citations
9Three decades of PRPs: keeping the flame alive for blood as a source of repair and regenerationExpert Opinion on Biological Therapy · 2026
10The double-edged sword: a contemporary perspective on biologics for anti-cytokine syndromesExpert Opinion on Biological Therapy · 2026

More from Expert Opinion on Biological Therapy

More from Universidad Nacional Autónoma de México

More from Autonomous University of San Luis Potosí

More from Autonomous University of Tlaxcala